134 related articles for article (PubMed ID: 37981929)
1. Unusual infection in a haploidentical transplant of Wiskott - Aldrich syndrome.
Ahuja A; Yanamandra U; Kapoor R; Chatterjee T
Med J Armed Forces India; 2023; 79(6):729-731. PubMed ID: 37981929
[No Abstract] [Full Text] [Related]
2. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning.
Sharma A; Rastogi N; Kapoor R; Chatterjee G; Yadav SP
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e230-e233. PubMed ID: 32459721
[TBL] [Abstract][Full Text] [Related]
3. Successful T replete haploidentical HSCT with post-transplant cyclophosphamide in two patients with Wiskott-Aldrich syndrome.
Kapoor R; Yanamandra U; Kumar R; Pramanik SK
Med J Armed Forces India; 2023; 79(6):722-725. PubMed ID: 37981926
[TBL] [Abstract][Full Text] [Related]
4. Un-manipulated Haploidentical Transplant in Wiskott-Aldrich Syndrome.
John MJ; Philip CC; Mathew A; Williams A; Kakkar N
Indian Pediatr; 2017 Apr; 54(4):327-328. PubMed ID: 28474594
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome.
Yue Y; Shi X; Song Z; Qin J; Li J; Feng S; Liu R
Pediatr Blood Cancer; 2018 Aug; 65(8):e27092. PubMed ID: 29745014
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
7. Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome.
Kreetapirom P; Hongeng S; Manuyakorn W; Anurathapan U; Pakakasama S; Sirachainan N; Andersson BS
Bone Marrow Transplant; 2017 Jun; 52(6):913-914. PubMed ID: 28287640
[No Abstract] [Full Text] [Related]
8. Six-Year Long Follow-up of Patient With Wiskott-Aldrich Syndrome Post Haploidentical Stem Cell Transplant.
Sachdev M; Chakraborty S; Bansal M; Dua V
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1252-e1253. PubMed ID: 33625090
[No Abstract] [Full Text] [Related]
9. Case Report: Haploidentical Bone Marrow Transplantation in Two Brothers With Wiskott-Aldrich Syndrome Using Their Father as the Donor.
Smith J; Alfonso JH; Reddivalla N; Angulo P; Katsanis E
Front Pediatr; 2021; 9():647505. PubMed ID: 34778119
[TBL] [Abstract][Full Text] [Related]
10. Wiskott-Aldrich syndrome that was initially diagnosed as immune thrombocytopenic purpura secondary to a cytomegalovirus infection.
Kaneko R; Yamamoto S; Okamoto N; Akiyama K; Matsuno R; Toyama D; Hoshino A; Imai K; Isoyama K
SAGE Open Med Case Rep; 2018; 6():2050313X17753788. PubMed ID: 29348920
[TBL] [Abstract][Full Text] [Related]
11. Wiskott Aldrich syndrome: an immunodeficiency syndrome not rare in Western Australia.
Somerville C; Forsyth KD
Pediatr Allergy Immunol; 1993 May; 4(2):65-72. PubMed ID: 8353648
[TBL] [Abstract][Full Text] [Related]
12. Wiskott-Aldrich syndrome in a family with Fanconi anemia.
Rohrer J; Ribeiro RC; Auerbach AD; Mirro B; Conley ME
J Pediatr; 1996 Jul; 129(1):50-5. PubMed ID: 8757562
[TBL] [Abstract][Full Text] [Related]
13. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
14. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
Filipovich AH; Stone JV; Tomany SC; Ireland M; Kollman C; Pelz CJ; Casper JT; Cowan MJ; Edwards JR; Fasth A; Gale RP; Junker A; Kamani NR; Loechelt BJ; Pietryga DW; Ringdén O; Vowels M; Hegland J; Williams AV; Klein JP; Sobocinski KA; Rowlings PA; Horowitz MM
Blood; 2001 Mar; 97(6):1598-603. PubMed ID: 11238097
[TBL] [Abstract][Full Text] [Related]
15. Haploidentical T-cell alpha beta receptor and CD19-depleted stem cell transplant for Wiskott-Aldrich syndrome.
Kharya G; Nademi Z; Leahy TR; Dunn J; Barge D; Schulz A; Cant A; Gennery A; Slatter M
J Allergy Clin Immunol; 2014 Nov; 134(5):1199-201. PubMed ID: 24985403
[No Abstract] [Full Text] [Related]
16. Clinical Features, Cancer Biology, Transplant Approach and Other Integrated Management Strategies for Wiskott-Aldrich Syndrome.
Hosahalli Vasanna S; Pereda MA; Dalal J
J Multidiscip Healthc; 2021; 14():3497-3512. PubMed ID: 34992377
[TBL] [Abstract][Full Text] [Related]
17. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.
Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V;
Haematologica; 2017 Jun; 102(6):1112-1119. PubMed ID: 28255019
[TBL] [Abstract][Full Text] [Related]
18. Wiskott-Aldrich syndrome: new molecular and biochemical insights.
Peacocke M; Siminovitch KA
J Am Acad Dermatol; 1992 Oct; 27(4):507-19. PubMed ID: 1401301
[TBL] [Abstract][Full Text] [Related]
19. Use of Thromboelastography to Guide Platelet Infusion in a Patient with Wiskott-Aldrich Syndrome Undergoing Renal Transplant.
Al Midani A; Donohue C; Berry P; Jones G; Fernando B
Exp Clin Transplant; 2020 Oct; 18(5):636-637. PubMed ID: 32281533
[TBL] [Abstract][Full Text] [Related]
20. Linking cellular activation to cytoskeletal reorganization: Wiskott-Aldrich syndrome as a model.
Stewart DM; Tian L; Nelson DL
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):525-33. PubMed ID: 11964736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
